These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure. Ocak N, Dirican M, Ersoy A, Sarandol E. Ren Fail; 2016 Nov; 38(10):1639-1646. PubMed ID: 27764985 [Abstract] [Full Text] [Related]
5. Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients. Spoto B, Mattace-Raso F, Sijbrands E, Pizzini P, Cutrupi S, D'Arrigo G, Tripepi G, Zoccali C, Mallamaci F. Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv181-7. PubMed ID: 23975745 [Abstract] [Full Text] [Related]
6. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR. Br J Nutr; 2015 Jun 28; 113(12):1920-30. PubMed ID: 25907896 [Abstract] [Full Text] [Related]
10. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis. Delgado C, Chertow GM, Kaysen GA, Dalrymple LS, Kornak J, Grimes B, Johansen KL. Am J Kidney Dis; 2017 Dec 28; 70(6):817-825. PubMed ID: 28870376 [Abstract] [Full Text] [Related]
12. Adipocytokines leptin and adiponectin, and measures of malnutrition-inflammation in chronic renal failure: is there a relationship? Dervisoglu E, Eraldemir C, Kalender B, Kir HM, Caglayan C. J Ren Nutr; 2008 Jul 28; 18(4):332-7. PubMed ID: 18558297 [Abstract] [Full Text] [Related]
13. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Zoccali C, Mallamaci F, Tripepi G. Kidney Int Suppl; 2003 May 28; (84):S65-8. PubMed ID: 12694312 [Abstract] [Full Text] [Related]
15. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M, Lacinova Z, Kudla M, Teplan V, Haluzik M. Nutrition; 2009 May 28; 25(7-8):762-8. PubMed ID: 19539174 [Abstract] [Full Text] [Related]
16. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. Mallamaci F, Tripepi G, Zoccali C. J Nephrol; 2005 May 28; 18(4):464-8. PubMed ID: 16245256 [Abstract] [Full Text] [Related]
18. Adiponectin and end-stage renal disease. Markaki A, Psylinakis E, Spyridaki A. Hormones (Athens); 2016 Jul 28; 15(3):345-354. PubMed ID: 27838604 [Abstract] [Full Text] [Related]
19. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Eur Cytokine Netw; 2006 Mar 28; 17(1):4-12. PubMed ID: 16613757 [Abstract] [Full Text] [Related]
20. Leptin/adiponectin ratio is an independent predictor of mortality in nondiabetic peritoneal dialysis patients. Park JT, Yoo TH, Kim JK, Oh HJ, Kim SJ, Yoo DE, Lee MJ, Shin DH, Han SH, Han DS, Kang SW. Perit Dial Int; 2013 Mar 28; 33(1):67-74. PubMed ID: 22855891 [Abstract] [Full Text] [Related] Page: [Next] [New Search]